The decision is among the four rulings that apparently came in line...
Category:
Disaster & Management
Latest
More people are affected by tropical cyclones in Asia than any other region
The study estimates that 6 to 12 per cent of the global population...
Special camps to be organised in TN’s 4 districts to settle insurance claims once flood water recedes: FM
As many as 31 people have lost their lives in the four districts...
Tokyo Olympics at risk if coronavirus mutates, gets stronger:Japan adviser
“I think the virus is mutating all the time … it may be a much stronger virus that triggers a second wave,” Kiyoshi Kurokawa, a prominent Japanese government adviser,told Reuters. “The Olympics may be postponed again, but I can’t predict.”
Positive news on Oxford/AstraZeneca COVID-19 vaccine could come Thursday:report
AstraZeneca’s experimental vaccine is probably the world’s leading candidate and most advanced in terms of development, the World Health Organization’s chief scientist said in June.
The company has signed agreements with governments around the globe to supply the vaccine should it be cleared for use.
India’s tech hub Bengaluru, other towns back in lockdown amid COVID-19 surge
In all, India has 906,752 cases of the novel coronavirus with 28,498 new infections reported on Tuesday, according to data from the federal health ministry, the third highest total in the world behind Brazil and the United States.
UK Plans to spend $6.6 billion on building flood defenses through 2027
Under the plans, the UK’s Flood Re insurance program will also be modified to allow claims to include the installation of flood resilience measures as well as repairs for affected properties.
“For every pound spent improving protection from flooding and coastal erosion, we avoid around 5 pounds of property damages,” Environment Agency Chairman Emma Howard Boyd said. “The long-term commitments announced today will make homes, businesses and infrastructure more resilient to the accelerating impacts of the climate crisis.”
India’s COVID-19 tally crosses 9 lakh with 28,498 fresh cases; death toll climbs to 23,727
The march of coronavirus infection in the country has picked up pace with the number of cases increasing by more than 26,000 for the fifth consecutive day. It took 110 days for the COVID-19 cases in the country to reach one lakh and just 56 days more to go past the nine-lakh mark.
Around 63.02 per cent of patients have recovered so far.
Human clinical trials for Covid-19 vaccine initiated in India:ICMR
The Drugs Controller General of India (DCGI) has permitted two vaccines — one developed by Bharat Biotech International Limited in collaboration with the Indian Council of Medical Research and another one by ZydasCadila Healthcare Ltd to go in for the first and second phase of human clinical trials.
There are two Indian vaccine candidates that have undergone successful toxicity studies in rats, mice and rabbits and these data was submitted to the DCGI, following which both got clearance to start an early phase human trials earlier this month, Bhargava said at a press briefing.
Govt approves Rs 107 cr for fire-fighting facilities at Haldia Dock
The modern fire-fighting facility will enable Haldia Dock Complex in safe handling of the movement of petro-chemical products, it said.
The existing fire-fighting facility does not support the handling the LPG and other petroleum products as per the guideline of Oil Industry Safety Directorate (OISD) of the Ministry of Petroleum and Natural Gas, it added.
The shipping ministry said it has prioritised safety and security of cargo operation on all major ports and the move is towards compliance of global standards for fire safety.
Record spike of 28,701 COVID-19 cases takes India’s tally to 8,78,254
Death toll climbed to 23,174 with 500 people succumbing to the infection, according to the Union Health Ministry data.
Around 63.01 per cent of patients have recovered so far”
Glenmark cuts price of COVID-19 drug favipiravir version to $1 per tablet
Glenmark last month received Indian regulatory approval to make and sell anti-flu drug favipiravir, which is manufactured under the brand name Avigan by a unit of Japan’s Fujifilm Holdings Corp.
Glenmark had priced FabiFlu at 103 rupees per tablet earlier, making it one of the cheapest COVID-19 treatment available in the country.
“Glenmark’s price reduction aims to make FabiFlu further accessible for COVID-19 patients across the country,” the company said in a statement
Counting the burials: African nations scramble to track COVID-19
Only eight countries in Africa – Algeria, Cape Verde, Djibouti, Egypt, Mauritius, Namibia, Seychelles, and South Africa – record more than 75% of deaths, according to the United Nations.